A 2024 retrospective analysis examined adults with sickle cell disease treated with GLP-1 RAs, demonstrating improvement in estimated glomerular filtration rate (eGFR) slope in 80% of patients receiving GLP-1 RA treatment [183]. The gene discussed is GLP1R; the disease is sickle cell disease.